wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q47897098-4B4F40B4-AF1A-4953-BA06-77A918E4E498
Q47897098-4B4F40B4-AF1A-4953-BA06-77A918E4E498
BestRank
Statement
http://www.wikidata.org/entity/statement/Q47897098-4B4F40B4-AF1A-4953-BA06-77A918E4E498
Phase 1/2 study of rilotumumab (AMG 102), a hepatocyte growth factor inhibitor, and erlotinib in patients with advanced non-small cell lung cancer.
P2860
Q47897098-4B4F40B4-AF1A-4953-BA06-77A918E4E498
BestRank
Statement
http://www.wikidata.org/entity/statement/Q47897098-4B4F40B4-AF1A-4953-BA06-77A918E4E498
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
d96549d6e649bd498f68f00190543fc221ff5f46
P2860
Randomized phase Ib/II trial of rilotumumab or ganitumab with panitumumab versus panitumumab alone in patients with wild-type KRAS metastatic colorectal cancer.